The International development of PROQOL-HCV: An instrument to assess the health-related quality of life of patients treated for Hepatitis C virus.
Identifieur interne : 001A15 ( PubMed/Corpus ); précédent : 001A14; suivant : 001A16The International development of PROQOL-HCV: An instrument to assess the health-related quality of life of patients treated for Hepatitis C virus.
Auteurs : Andrew Richard Armstrong ; Susan Elizabeth Herrmann ; Olivier Chassany ; Christophe Lalanne ; Mariliza Henrique Da Silva ; Eliana Galano ; Patrizia M. Carrieri ; Vincent Estellon ; Philippe Sogni ; Martin DuracinskySource :
- BMC infectious diseases [ 1471-2334 ] ; 2016.
English descriptors
- KwdEn :
- Adult, Australia, Brazil, Fatigue, Female, France, Health Status Indicators, Hepacivirus (physiology), Hepatitis C (psychology), Hepatitis C (therapy), Humans, International Cooperation, Male, Middle Aged, Pilot Projects, Psychometrics (methods), Psychometrics (standards), Quality of Life (psychology), Surveys and Questionnaires (standards).
- MESH :
- methods : Psychometrics.
- physiology : Hepacivirus.
- psychology : Hepatitis C, Quality of Life.
- standards : Psychometrics, Surveys and Questionnaires.
- therapy : Hepatitis C.
- Adult, Australia, Brazil, Fatigue, Female, France, Health Status Indicators, Humans, International Cooperation, Male, Middle Aged, Pilot Projects.
Abstract
Hepatitis C virus (HCV) compromises Health-related Quality of Life (HRQL) with detriments to Physical, Mental and Social health domains. Treatment with interferon and ribavirin is associated with side effects which further impair HRQL. New treatments appear potent, effective and tolerable. However, Patient Reported Outcomes instruments that capture the impact on HRQL for people with hepatitis C are largely non-specific and will be needed in the new treatment era. Therefore, we developed a conceptually valid multidimensional model of HCV-specific quality of life and pilot survey instrument, the Patient Reported Outcome Quality of Life survey for HCV (PROQOL-HCV).
DOI: 10.1186/s12879-016-1771-0
PubMed: 27553866
Links to Exploration step
pubmed:27553866Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The International development of PROQOL-HCV: An instrument to assess the health-related quality of life of patients treated for Hepatitis C virus.</title>
<author><name sortKey="Armstrong, Andrew Richard" sort="Armstrong, Andrew Richard" uniqKey="Armstrong A" first="Andrew Richard" last="Armstrong">Andrew Richard Armstrong</name>
<affiliation><nlm:affiliation>EA 7334 REMES, Patient-Centered Outcomes Research, University Paris-Diderot, Sorbonne Paris Cité, Paris, France. Andrew74.psy@gmail.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Herrmann, Susan Elizabeth" sort="Herrmann, Susan Elizabeth" uniqKey="Herrmann S" first="Susan Elizabeth" last="Herrmann">Susan Elizabeth Herrmann</name>
<affiliation><nlm:affiliation>Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chassany, Olivier" sort="Chassany, Olivier" uniqKey="Chassany O" first="Olivier" last="Chassany">Olivier Chassany</name>
<affiliation><nlm:affiliation>EA 7334 REMES, Patient-Centered Outcomes Research, University Paris-Diderot, Sorbonne Paris Cité, Paris, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lalanne, Christophe" sort="Lalanne, Christophe" uniqKey="Lalanne C" first="Christophe" last="Lalanne">Christophe Lalanne</name>
<affiliation><nlm:affiliation>EA 7334 REMES, Patient-Centered Outcomes Research, University Paris-Diderot, Sorbonne Paris Cité, Paris, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Da Silva, Mariliza Henrique" sort="Da Silva, Mariliza Henrique" uniqKey="Da Silva M" first="Mariliza Henrique" last="Da Silva">Mariliza Henrique Da Silva</name>
<affiliation><nlm:affiliation>Centro de Referência e Treinamento DST/Aids, Rue santa Cruz, Sao Paulo, Brazil.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Galano, Eliana" sort="Galano, Eliana" uniqKey="Galano E" first="Eliana" last="Galano">Eliana Galano</name>
<affiliation><nlm:affiliation>Centro de Referência e Treinamento DST/Aids, Rue santa Cruz, Sao Paulo, Brazil.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Carrieri, Patrizia M" sort="Carrieri, Patrizia M" uniqKey="Carrieri P" first="Patrizia M" last="Carrieri">Patrizia M. Carrieri</name>
<affiliation><nlm:affiliation>U912 (SE4S), INSERM, Marseille, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Estellon, Vincent" sort="Estellon, Vincent" uniqKey="Estellon V" first="Vincent" last="Estellon">Vincent Estellon</name>
<affiliation><nlm:affiliation>Université Paris Descartes, Paris, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sogni, Philippe" sort="Sogni, Philippe" uniqKey="Sogni P" first="Philippe" last="Sogni">Philippe Sogni</name>
<affiliation><nlm:affiliation>Service d'Hépatologie, Hopital Cochin, AP-HP, Paris, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Duracinsky, Martin" sort="Duracinsky, Martin" uniqKey="Duracinsky M" first="Martin" last="Duracinsky">Martin Duracinsky</name>
<affiliation><nlm:affiliation>EA 7334 REMES, Patient-Centered Outcomes Research, University Paris-Diderot, Sorbonne Paris Cité, Paris, France.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27553866</idno>
<idno type="pmid">27553866</idno>
<idno type="doi">10.1186/s12879-016-1771-0</idno>
<idno type="wicri:Area/PubMed/Corpus">001A15</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001A15</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The International development of PROQOL-HCV: An instrument to assess the health-related quality of life of patients treated for Hepatitis C virus.</title>
<author><name sortKey="Armstrong, Andrew Richard" sort="Armstrong, Andrew Richard" uniqKey="Armstrong A" first="Andrew Richard" last="Armstrong">Andrew Richard Armstrong</name>
<affiliation><nlm:affiliation>EA 7334 REMES, Patient-Centered Outcomes Research, University Paris-Diderot, Sorbonne Paris Cité, Paris, France. Andrew74.psy@gmail.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Herrmann, Susan Elizabeth" sort="Herrmann, Susan Elizabeth" uniqKey="Herrmann S" first="Susan Elizabeth" last="Herrmann">Susan Elizabeth Herrmann</name>
<affiliation><nlm:affiliation>Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chassany, Olivier" sort="Chassany, Olivier" uniqKey="Chassany O" first="Olivier" last="Chassany">Olivier Chassany</name>
<affiliation><nlm:affiliation>EA 7334 REMES, Patient-Centered Outcomes Research, University Paris-Diderot, Sorbonne Paris Cité, Paris, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lalanne, Christophe" sort="Lalanne, Christophe" uniqKey="Lalanne C" first="Christophe" last="Lalanne">Christophe Lalanne</name>
<affiliation><nlm:affiliation>EA 7334 REMES, Patient-Centered Outcomes Research, University Paris-Diderot, Sorbonne Paris Cité, Paris, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Da Silva, Mariliza Henrique" sort="Da Silva, Mariliza Henrique" uniqKey="Da Silva M" first="Mariliza Henrique" last="Da Silva">Mariliza Henrique Da Silva</name>
<affiliation><nlm:affiliation>Centro de Referência e Treinamento DST/Aids, Rue santa Cruz, Sao Paulo, Brazil.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Galano, Eliana" sort="Galano, Eliana" uniqKey="Galano E" first="Eliana" last="Galano">Eliana Galano</name>
<affiliation><nlm:affiliation>Centro de Referência e Treinamento DST/Aids, Rue santa Cruz, Sao Paulo, Brazil.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Carrieri, Patrizia M" sort="Carrieri, Patrizia M" uniqKey="Carrieri P" first="Patrizia M" last="Carrieri">Patrizia M. Carrieri</name>
<affiliation><nlm:affiliation>U912 (SE4S), INSERM, Marseille, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Estellon, Vincent" sort="Estellon, Vincent" uniqKey="Estellon V" first="Vincent" last="Estellon">Vincent Estellon</name>
<affiliation><nlm:affiliation>Université Paris Descartes, Paris, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sogni, Philippe" sort="Sogni, Philippe" uniqKey="Sogni P" first="Philippe" last="Sogni">Philippe Sogni</name>
<affiliation><nlm:affiliation>Service d'Hépatologie, Hopital Cochin, AP-HP, Paris, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Duracinsky, Martin" sort="Duracinsky, Martin" uniqKey="Duracinsky M" first="Martin" last="Duracinsky">Martin Duracinsky</name>
<affiliation><nlm:affiliation>EA 7334 REMES, Patient-Centered Outcomes Research, University Paris-Diderot, Sorbonne Paris Cité, Paris, France.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">BMC infectious diseases</title>
<idno type="eISSN">1471-2334</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Australia</term>
<term>Brazil</term>
<term>Fatigue</term>
<term>Female</term>
<term>France</term>
<term>Health Status Indicators</term>
<term>Hepacivirus (physiology)</term>
<term>Hepatitis C (psychology)</term>
<term>Hepatitis C (therapy)</term>
<term>Humans</term>
<term>International Cooperation</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pilot Projects</term>
<term>Psychometrics (methods)</term>
<term>Psychometrics (standards)</term>
<term>Quality of Life (psychology)</term>
<term>Surveys and Questionnaires (standards)</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Psychometrics</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Hepacivirus</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Hepatitis C</term>
<term>Quality of Life</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Psychometrics</term>
<term>Surveys and Questionnaires</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Hepatitis C</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Australia</term>
<term>Brazil</term>
<term>Fatigue</term>
<term>Female</term>
<term>France</term>
<term>Health Status Indicators</term>
<term>Humans</term>
<term>International Cooperation</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pilot Projects</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Hepatitis C virus (HCV) compromises Health-related Quality of Life (HRQL) with detriments to Physical, Mental and Social health domains. Treatment with interferon and ribavirin is associated with side effects which further impair HRQL. New treatments appear potent, effective and tolerable. However, Patient Reported Outcomes instruments that capture the impact on HRQL for people with hepatitis C are largely non-specific and will be needed in the new treatment era. Therefore, we developed a conceptually valid multidimensional model of HCV-specific quality of life and pilot survey instrument, the Patient Reported Outcome Quality of Life survey for HCV (PROQOL-HCV).</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27553866</PMID>
<DateCreated><Year>2016</Year>
<Month>08</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>06</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>06</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>16</Volume>
<Issue>1</Issue>
<PubDate><Year>2016</Year>
<Month>Aug</Month>
<Day>23</Day>
</PubDate>
</JournalIssue>
<Title>BMC infectious diseases</Title>
<ISOAbbreviation>BMC Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>The International development of PROQOL-HCV: An instrument to assess the health-related quality of life of patients treated for Hepatitis C virus.</ArticleTitle>
<Pagination><MedlinePgn>443</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-016-1771-0</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hepatitis C virus (HCV) compromises Health-related Quality of Life (HRQL) with detriments to Physical, Mental and Social health domains. Treatment with interferon and ribavirin is associated with side effects which further impair HRQL. New treatments appear potent, effective and tolerable. However, Patient Reported Outcomes instruments that capture the impact on HRQL for people with hepatitis C are largely non-specific and will be needed in the new treatment era. Therefore, we developed a conceptually valid multidimensional model of HCV-specific quality of life and pilot survey instrument, the Patient Reported Outcome Quality of Life survey for HCV (PROQOL-HCV).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">HCV patients from France (n = 30), Brazil (n = 20) and Australia (n = 20) were interviewed to investigate HCV-HRQL issues raised in the scientific literature and by treatment specialists. Interviews were recorded, transcribed and translated into English and French.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifteen content dimensions were derived from the qualitative analysis, refined and fitted to four domains: (1) Physical Health included: fatigue, pain, sleep, sexual impairment and physical activity; (2) Mental Health: psychological distress, psychosocial impact, and cognition; (3) Social Health: support, stigma, social activity, substance use; (4) TREATMENT: management, side effects, and fear of treatment failure. The impact of some dimensions extended beyond their primary domain including: physical activity, cognition, sleep, sexual impairment, and the three treatment dimensions. A bank of 300 items was constructed to reflect patient reports and, following expert review, reduced to a 72-item pilot questionnaire.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We present a conceptually valid multidimensional model of HCV-specific quality of life and the pilot survey instrument, PROQOL-HCV. The model is widely inclusive of the experience of hepatitis C and the first to include the treatment dimension.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Armstrong</LastName>
<ForeName>Andrew Richard</ForeName>
<Initials>AR</Initials>
<AffiliationInfo><Affiliation>EA 7334 REMES, Patient-Centered Outcomes Research, University Paris-Diderot, Sorbonne Paris Cité, Paris, France. Andrew74.psy@gmail.com.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Australian Institute of Family Studies, Melbourne, Australia. Andrew74.psy@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Herrmann</LastName>
<ForeName>Susan Elizabeth</ForeName>
<Initials>SE</Initials>
<AffiliationInfo><Affiliation>Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chassany</LastName>
<ForeName>Olivier</ForeName>
<Initials>O</Initials>
<AffiliationInfo><Affiliation>EA 7334 REMES, Patient-Centered Outcomes Research, University Paris-Diderot, Sorbonne Paris Cité, Paris, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>URC-ECO, Hopital Hotel-Dieu, AP-HP, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lalanne</LastName>
<ForeName>Christophe</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>EA 7334 REMES, Patient-Centered Outcomes Research, University Paris-Diderot, Sorbonne Paris Cité, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Da Silva</LastName>
<ForeName>Mariliza Henrique</ForeName>
<Initials>MH</Initials>
<AffiliationInfo><Affiliation>Centro de Referência e Treinamento DST/Aids, Rue santa Cruz, Sao Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Galano</LastName>
<ForeName>Eliana</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Centro de Referência e Treinamento DST/Aids, Rue santa Cruz, Sao Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Carrieri</LastName>
<ForeName>Patrizia M</ForeName>
<Initials>PM</Initials>
<AffiliationInfo><Affiliation>U912 (SE4S), INSERM, Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Estellon</LastName>
<ForeName>Vincent</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Université Paris Descartes, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sogni</LastName>
<ForeName>Philippe</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Service d'Hépatologie, Hopital Cochin, AP-HP, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Duracinsky</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>EA 7334 REMES, Patient-Centered Outcomes Research, University Paris-Diderot, Sorbonne Paris Cité, Paris, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>URC-ECO, Hopital Hotel-Dieu, AP-HP, Paris, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Service de Médecine Interne et d'Immunologie Clinique, Hopital Bicetre, AP-HP, Kremlin-Bicetre, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D023361">Validation Studies</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>08</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>BMC Infect Dis</MedlineTA>
<NlmUniqueID>100968551</NlmUniqueID>
<ISSNLinking>1471-2334</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Dig Liver Dis. 2014 Dec 15;46 Suppl 5:S186-96</RefSource>
<PMID Version="1">25458773</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Health Qual Life Outcomes. 2012 Aug 07;10:92</RefSource>
<PMID Version="1">22871087</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Gastroenterol. 2006 Jun;101(6):1235-43</RefSource>
<PMID Version="1">16771944</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychosomatics. 2008 Nov-Dec;49(6):494-501</RefSource>
<PMID Version="1">19122126</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Gastroenterol. 2000 Dec;95(12):3552-65</RefSource>
<PMID Version="1">11151892</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Top Antivir Med. 2014 Jan;21(5):152-6</RefSource>
<PMID Version="1">24531555</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2007 Mar;45(3):806-16</RefSource>
<PMID Version="1">17326207</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 2014 Mar;23(2):561-70</RefSource>
<PMID Version="1">24005885</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gastroenterol Nurs. 2009 Nov-Dec;32(6):401-8</RefSource>
<PMID Version="1">20010233</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Epidemiol. 2010 Feb;25(2):143-8</RefSource>
<PMID Version="1">20084429</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 2004 Oct;13(8):1469-81</RefSource>
<PMID Version="1">15503842</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2015 Feb;148(2):355-366.e1</RefSource>
<PMID Version="1">25311593</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gut. 1999 Aug;45(2):295-300</RefSource>
<PMID Version="1">10403745</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Med. 2013 Jul;19(7):850-8</RefSource>
<PMID Version="1">23836235</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2015 May;61(5):1471-8</RefSource>
<PMID Version="1">25706754</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 1995 Jan 4;273(1):59-65</RefSource>
<PMID Version="1">7996652</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 2014 Apr;23(3):877-86</RefSource>
<PMID Version="1">24036634</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Infect Dis. 2015 Jan 17;15:19</RefSource>
<PMID Version="1">25596623</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gastroenterol Nurs. 2009 Mar-Apr;32(2):94-104</RefSource>
<PMID Version="1">19357473</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2015 Jun 15;60(12):1829-36</RefSource>
<PMID Version="1">25761867</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Epidemiol. 2001 Dec;54 Suppl 1:S77-90</RefSource>
<PMID Version="1">11750213</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 1998 Jan;7(1):39-55</RefSource>
<PMID Version="1">9481150</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 2013 Sep;22(7):1525-35</RefSource>
<PMID Version="1">23070749</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Aliment Pharmacol Ther. 2015 Mar;41(6):497-520</RefSource>
<PMID Version="1">25616122</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2005 Aug 1;41(3):395-402</RefSource>
<PMID Version="1">16007539</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Viral Hepat. 2014 May;21 Suppl 1:1-4</RefSource>
<PMID Version="1">24713003</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Epidemiol. 2016 Apr;72:116-25</RefSource>
<PMID Version="1">26548542</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Health Qual Life Outcomes. 2006 Oct 11;4:79</RefSource>
<PMID Version="1">17034633</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N">Australia</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N">Brazil</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N">France</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006305" MajorTopicYN="Y">Health Status Indicators</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016174" MajorTopicYN="N">Hepacivirus</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006526" MajorTopicYN="N">Hepatitis C</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007391" MajorTopicYN="N">International Cooperation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011795" MajorTopicYN="Y">Surveys and Questionnaires</DescriptorName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4994204</OtherID>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Health status</Keyword>
<Keyword MajorTopicYN="N">Hepatitis c</Keyword>
<Keyword MajorTopicYN="N">Quality of life</Keyword>
<Keyword MajorTopicYN="N">Questionnaires</Keyword>
<Keyword MajorTopicYN="N">Research methods</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year>
<Month>12</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>08</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>8</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>8</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>6</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27553866</ArticleId>
<ArticleId IdType="doi">10.1186/s12879-016-1771-0</ArticleId>
<ArticleId IdType="pii">10.1186/s12879-016-1771-0</ArticleId>
<ArticleId IdType="pmc">PMC4994204</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A15 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001A15 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:27553866 |texte= The International development of PROQOL-HCV: An instrument to assess the health-related quality of life of patients treated for Hepatitis C virus. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:27553866" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |